Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer ...Middle East

LUND, Sweden, Dec. 9, 2024 /PRNewswire/ -- Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer) to detect early-stage pancreatic...

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer )

Also on site :

• Terrorist plot foiled in Russia’s Kaliningrad – FSB
• Old Navy Is Selling a 'Very Comfortable' Mini Dress for Just $17, and Shoppers Say It’s 'Perfect' for Summer
• Your Next 3 Years: What Happens When Saturn Enters Aries